login
Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Investigational Drug Being Pursued for the Treatment of Ischaemic Stroke
June 01, 2007 at 12:27 PM
Drug News
"We have data showing that fibrinogen plays a significant role in influencing stroke outcome. Ancrod directly targets fibrinogen and has the potential to treat strokes by rapidly lowering fibrinogen levels," said David E. Levy, MD, Vice President of Clinical Development for NTI.
"We are aggressively recruiting patients worldwide for the ASP-I and ASP-II studies. We hope by garnering a large patient base for the study we can generate the robust data needed to confirm our new dosing strategy and six hour treatment window for acute ischaemic stroke."
Source: PRNewswire
LIN/M
|
|
|
More News on: Drug Toxicity, Bells Palsy, Diet Lifestyle and Heart Disease, Mitral Valve Stenosis And Mitral Valve Replacement, Congenital Heart Disease, Signature Drug Toxicity, Stress and the Gender Divide, Stroke Facts, Stroke, Geriatry-Related Diseases
 Comment & Contribute
|
Medwonders Health Network
- Health News Index
- News Quick Links
 |
Stroke
Complete Medindia Resources
|
| News Categories: |
| » | Vivek Oberoi Says There is No Smoking on His Sets |
| » | Gasoigne Swaps Booze for Botox |
| » | Michelle Obama: Name of Olive Tree in Italy |
| » | Beyonce: Most Beautiful Women in the World |
| » | Robin Gibb Recovers from Coma Wakes Up to Cancer |
| More Celebrity News | |
|
